Modulation of autophagy with hydroxychloroquine in patients with advanced non-small cell lung cancer (NSCLC): A phase Ib study.

被引：9
|
作者：
Malhotra, Jyoti
Jabbour, Salma
Orlick, Michelle
Riedlinger, Gregory
Joshi, Sonali
Guo, Jessie Yanxiang
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21138
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of Cemiplimab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Papachristos, A.
    Masinde, S.
    Davis, J. D.
    Gullo, G.
    Rietschel, P.
    Paccaly, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S308 - S309
  • [22] A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer
    Shafique, Michael R.
    Fisher, Terrence L.
    Evans, Elizabeth E.
    Leonard, John E.
    Pastore, Desa Rae E.
    Mallow, Crystal L.
    Smith, Ernest
    Mishra, Vikas
    Schroeder, Andreas
    Chin, Kevin M.
    Beck, Joseph T.
    Baumgart, Megan A.
    Govindan, Ramaswamy
    Gabrail, Nashat Y.
    Spira, Alexander I.
    Seetharamu, Nagashree
    Lou, Yanyan
    Mansfield, Aaron S.
    Sanborn, Rachel E.
    Goldman, Jonathan W.
    Zauderer, Maurice
    CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3630 - 3640
  • [23] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    LUNG CANCER, 2002, 38 : S47 - S50
  • [24] Pilot Study of Inhaled Azacitidine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Cheng, H.
    Zou, Y.
    Shah, C.
    Fan, N.
    Bhagat, T.
    Gucalp, R.
    Kim, M.
    Verma, A.
    Piperdi, B.
    Spivack, S.
    Halmos, B.
    Perez-Soler, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S237 - S238
  • [25] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)
    Kim, Se Hyun
    Shim, Hyo Sup
    Cho, Jaeho
    Jeong, Jae Heon
    Kim, Sun Mi
    Hong, Yun Kyoung
    Sung, Ji Hee
    Ha, Sang-Jun
    Kim, Hye Ryun
    Chang, Hyun
    Kim, Joo Hang
    Tania, Crombet
    Cho, Byoung Chul
    LUNG CANCER, 2013, 79 (03) : 270 - 275
  • [26] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC).
    Kim, Han Sang
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] A phase II study of nedaplatin (CDGP) and docetaxel (TXT) in patients with advanced non-small cell lung cancer (NSCLC)
    Fujino, S.
    Asada, Y.
    Nakano, Y.
    Suzumura, Y.
    Inoue, S.
    Nagao, T.
    Hajiro, T.
    Tezuka, N.
    Sawai, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] A multicenter phase II study of sorafenib in combination with erlotinib patients with advanced non-small cell lung cancer (NSCLC)
    Cho, B.
    Kim, S.
    Heo, D. S.
    Kang, S.
    Kim, H.
    Lee, D.
    Kim, D.
    Jung, M.
    Choi, J.
    Kim, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)
    Jordi Rodon
    Charlotte D. Jacobs
    Quincy Chu
    Eric K. Rowinsky
    Arturo Lopez-Anaya
    Chris H. Takimoto
    Heather A. Wakelee
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 825 - 834
  • [30] Phase I/II study of exisulind and gemcitabine in patients with recurrent advanced non-small cell lung cancer (NSCLC).
    Hoang, T
    Kim, K
    Merchant, J
    Traynor, AM
    Ahuja, HG
    Masters, GA
    McGovern, JD
    Oettel, KR
    Sanchez, FA
    Schiller, JH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 642S - 642S
12345